Loading...
•
Jun 30, 2020
Prothena Q2 2020 Earnings Report
Reported financial results for the second quarter and first six months of 2020.
Key Takeaways
Prothena reported a net loss of $26.3 million for the second quarter of 2020, compared to a net loss of $15.8 million for the same period in 2019. Total revenue was $0.2 million, primarily from the collaboration with Roche. As of June 30, 2020, Prothena had $336.6 million in cash, cash equivalents and restricted cash.
Net loss of $26.3 million, or $0.66 per share, compared to a net loss of $15.8 million, or $0.40 per share, for the second quarter of 2019.
Total revenue of $0.2 million compared to $0.2 million for the second quarter of 2019.
Research and development expenses totaled $17.3 million, compared to $9.6 million for the second quarter of 2019.
Cash, cash equivalents and restricted cash totaled $336.6 million as of June 30, 2020.
Prothena
Prothena
Prothena Revenue by Segment
Revenue by Segment
Collaboration Revenue
CapyFin.com Forward Guidance
The Company continues to expect its full year 2020 net cash burn from operating and investing activities to be $75-$85 million, and expects to end the year with approximately $299 million in cash, cash equivalents and restricted cash (midpoint).